Untreated bacteriuria during pregnancy is associated with adverse maternal and perinatal outcomes. It is cost effective to screen for bacteriuria if the prevalence rate is 2% or more. The prevalence rate in this study was 3.6%. 67% of the aetiological agents belonged to the coliform group and balance 33% were staphylococci. All isolates were sensitive to nitrofurantoin. There was no association between bacteriuria and risk factors such as gestational diabetes, past urinary tract infection,

more »

... parity, advanced maternal age, lower education level, advanced gestational age and lower socioeconomic status. Screening of pregnant mothers is reported to be cost effective if the prevalence rates are ≥2%. It is recommended to screen pregnant mothers early in their pregnancy and treat those with significant bacteriuria as this could significantly minimize adverse maternal and foetal outcomes.